ZBH · Company KPIs
Zimmer Biomet (ZBH) KPIs
Organic constant currency net sales growth, Constant currency net sales growth. As reported in SEC filings, with the source line for each figure.
Organic constant currency net sales growth
4% for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 4% | Total · $2,177.0 · 4.8% · 4.7% · 4.0%8-K filed 2026-08-05 |
| Mar 31, 2026 | 2.9% | Total · $2,086.7 · 9.3% · 6.8% · 2.9%8-K filed 2026-04-28 |
| Dec 31, 2025 | 5.4% | Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basis8-K filed 2026-02-10 |
| Sep 30, 2025 | 5% | Total · $2,001.4 · 9.7% · 8.6% · 5.0%8-K filed 2025-11-05 |
Constant currency net sales growth
4.7% for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | 4.7% | Total · $2,177.0 · 4.8% · 4.7% · 4.0%8-K filed 2026-08-05 |
| Mar 31, 2026 | 6.8% | Total · $2,086.7 · 9.3% · 6.8% · 2.9%8-K filed 2026-04-28 |
| Dec 31, 2025 | 9.2% | Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basis8-K filed 2026-02-10 |
| Sep 30, 2025 | 8.6% | Total · $2,001.4 · 9.7% · 8.6% · 5.0%8-K filed 2025-11-05 |
| Jun 30, 2025 | 5.4% | Total · $2,077.3 · 7.0% · 5.4% · 2.8%8-K filed 2025-08-07 |
Reading notes
Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.